Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Akers Biosciences (AKER)

Akers Biosciences (AKER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Akers Biosciences 201 GROVE RD THOROFARE NJ 08086 USA

www.akersbio.com P: 856-848-8698

Description:

Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company's products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.

Key Statistics

Overview:

Market Capitalization, $K 41,133
Shares Outstanding, K 16,653
Annual Sales, $ 0 K
Annual Net Income, $ -17,580 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,287 K
60-Month Beta 0.33
% of Insider Shareholders 0.29%
% of Institutional Shareholders 6.24%
Float, K 16,605
% Float 99.71%

Growth:

1-Year Return -32.14%
3-Year Return -97.66%
5-Year Return -99.19%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/21/21
Earnings Per Share ttm -1.07
EPS Growth vs. Prev Qtr 44.93%
EPS Growth vs. Prev Year 77.36%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-2 on 04/19/21

AKER Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -62.79%
Return-on-Assets % -55.01%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales -114.26
Price/Cash Flow N/A
Price/Book 1.26
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar